Abstract
Introduction

Until recently, advanced age, family history and apolipoprotein E (apoE) 4 allele have been the only established risk factors for Alzheimer's disease (AD). The apoE 4 allele is the most important
currently known genetic risk factor for AD, and it may represent roughly half of the genetic risk for AD [1, 2] . Dominance of the genetic hypotheses for AD has lead to somewhat fatalistic attitude towards the possibilities to prevent or postpone the onset of it. However, this picture has recently started to change due to increasing evidence that modifiable risk factors for dementia and AD also exist [3] [4] [5] [6] [7] . Consequently, AD, the major form of dementia is currently considered to be a disease of multi-factorial origin, resulting from an interaction between the genetic susceptibility and environmental risk factors. Recent studies have linked dementia and AD with several lifestyle-related factors including physical activity [4, [8] [9] [10] [11] [12] , dietary fat and fish oil intake [6, [13] [14] [15] [16] [17] [18] , alcohol drinking [5, [19] [20] [21] [22] and smoking [23] [24] [25] [26] . Further, some studies have also suggested that the apoE 4 carrier status could be a possible effect modifier for the associations between lifestyle/vascular risk factors and dementia [4-6, 11, 14, 16-18, 20, 22, 27-30] 
Materials and methods
Participants
The participants of the Cardiovascular risk factors, Aging and Dementia (CAIDE) study were randomly selected from the survivors of four separate, independent, population-based random samples examined within the North Karelia Project and the FINMONICA study. These surveys were carried out to assess the levels of cardiovascular risk factors in two eastern provinces of Finland; North Karelia and Kuopio. The study design has been described in detail elsewhere [31] .
After being examined once at midlife (either in 1972, 1977, 1982 or 1987) , 2000 
Re-examination
During the re-examination in 1998, the survey methods used were identical to those applied in the previous surveys. Furthermore, the participants were studied for their apoE genotypes by use of PCR and Hhal digestion [32] . For the current study, the apoE genotypes were dichotomized into: Figure 2 [4-6, 11, 14, 16-18, 20, 22, 25-30] . Results from our group, as well as some others, have supported the hypothesis that the apoE 4 carriers are more vulnerable to various hazardous lifestyle related and vascular risk factors [4-6, 14, 16, 20, 29, 30, 39] . However, some studies have shown opposite results [11, 17, 18, 22, 25, 26] 
Results
Socio-demographic and clinical characteristics
Combined effect of lifestyle factors and the apoE carrier status
while
Fig. 2 Combined effects of various lifestyle-related factors and ApoE 4 carrier status for dementia. The values are odds ratios from logistic regression analysis adjusted with age, sex, follow-up time, education, body mass index, serum cholesterol, systolic blood pressure, and the history of myocardial infarction, stroke, and diabetes mellitus (the analyses for dietary fats are additionally adjusted for other subtypes of dietary fats and the analyses for physical activity additionally for locomotor disorders). Significant results are marked with * (P < 0.05) and ** (P < 0.001).
others found no effect modification [9, 13, 15, 24] [40] . Apart from our previous studies [4] [5] [6] , only few epidemiological studies exist with follow-up times up to 20 years investigating the effects of lifestyle-related factors and taking also into account the possible effect modification by the apoE 4 allele. One study focusing on smoking and with a follow-up time comparable to that of our study did not find any difference in the effect of smoking on the risk of dementia regarding to the apoE 4 carrier status [24] . Interestingly, apoE 4 may also modify effects of some drug treatments; a greater benefit has been suggested for the apoE 4 carriers with acetylcholinesterase inhibitor donepezil in mild cognitive impairment [41] , and atorvastatin in AD patients [42] .
Accumulating evidence has implicated that the apoE 4 allele influences not only AD, but also atherosclerosis and several other neurological disorders. A common molecular mechanism by which the apoE 4 allele contributes to neurodegeneration has been suggested. Interestingly, apoE has been linked to all the major features in AD pathogenesis including ␤-amyloid generation and clearance, neurofibrillary tangle formation, oxidative stress, apoptosis, dysfunction in lipid transport and homeostasis, modulation of intracellular signalling and synaptic plasticity [43] . In all cases, the presence of the apoE 4 allele has been shown to exacerbate these disturbances, in contrast to the protection seen with other apoE isoforms [43] . Further, apoE plays a key role in the maintenance and repair of neurons, and the apoE 4 allele carriers show a poor compensation of neuronal loss in different brain regions [44] . Also treatment of neuronal cultures with reconstituted apoE3 enhances neurite outgrowth, whereas apoE4 treatment decreases synaptic plasticity [45] . Some studies have suggested that apoE4 transgenic mice might be more susceptible to such environmental factors that can be considered detrimental or stressing [46, 47] . Further, several reports have shown different deficit in apoE 4 knock-in mice compared with those carrying the 3, including altered astroglial organization [48] , long-term potentiation [49] , amyloid precursor protein (APP) processing [50] and cholinergic deficits [51] [4-6, 14, 16, 20, 29, 30] [52] , physical inactivity [53] , unhealthy dietary pattern [53] , smoking [53] and heavy acute load of alcohol [54] 
